EHA 2017 | Future challenges facing hematological malignancies
Robin Foà, MD from Sapienza University of Rome, Rome, Italy highlights the major challenges that patients, scientists and doctors will face in the future when managing hematological malignancies. He explains how the patient should always be the central component to managing disease. However, due to political instability and health inequalities, the patient often gets pushed to the side. Furthermore, society’s view on age has changed dramatically. As life expectancy has increased, the aim of medicine will be to ensure that patients can live up to or beyond that point. Treatments will have to constantly evolve to meet those expectations. This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.
Get great new content delivered to your inboxSign up